The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5039983 6075130 I 5039983-8 20060622 20060623 20060630 EXP 2006UW13316 AZPRODUW00 41 YR F Y 46.1 KG 20060630 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5039983 1007429045 PS IRESSA 1 ORAL 21399
5039983 1007429046 SS CAPECITABINE 2

Indications of drugs used

Event ID DRUG SEQ INDI PT
5039983 1007429045 BREAST CANCER METASTATIC
5039983 1007429046 BREAST CANCER METASTATIC

Outcome of event

Event ID OUTC COD
5039983 HO

Reactions reported

Event ID PT
5039983 PANCREATITIS ACUTE
5039983 URINARY TRACT INFECTION

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5039983 1007429045 20050819 20060618 304 DAY
5039983 1007429046 20050819 20060618 304 DAY